Ovarian morphometrics in TP53-deficient mice
نویسندگان
چکیده
منابع مشابه
TP53 and ovarian cancer.
Ovarian cancer represents the fourth most frequent type of cancer among females and is the leading cause of death from gynecological cancer in the western world. This review describes gene alterations in ovarian cancer. Specific emphasis is placed on genetic alterations and the prevalence of TP53 (p53) gene alterations in the distinct biological ovarian tumors (benign, borderline, and malignant...
متن کاملPremature ovarian aging in mice deficient for Gpr3.
After becoming competent for resuming meiosis, fully developed mammalian oocytes are maintained arrested in prophase I until ovulation is triggered by the luteotropin surge. Meiotic pause has been shown to depend critically on maintenance of cAMP level in the oocyte and was recently attributed to the constitutive Gs (the heterotrimeric GTP-binding protein that activates adenylyl cyclase) signal...
متن کاملTP53 mutations in epithelial ovarian cancer
Genomic sequencing analyses of a variety of human cancers have revealed that massive mutations of cancer-relevant genes are the major alterations in cancerous cells, and their mutation frequencies or rates are highly associated with the development, progression, metastasis, and drug resistance of cancers as well as their clinical outcomes and prognosis. One predominant genetic alternation in hu...
متن کاملOncomorphic Tp53 mutations in advanced serous ovarian carcinomas
for advising me on the oncology related aspects of my project. From numerous discussions to collecting patient samples and allowing me to watch a surgery, his input was instrumental. I would also like to thank my committee members, Dr. me with encouragement and experimental insight. friends I have made along the way, who have given me unwavering support. My parents planted the curiosity for kno...
متن کاملThe Consequence of Oncomorphic TP53 Mutations in Ovarian Cancer
Ovarian cancer is the most lethal gynecological malignancy, with an alarmingly poor prognosis attributed to late detection and chemoresistance. Initially, most tumors respond to chemotherapy but eventually relapse due to the development of drug resistance. Currently, there are no biological markers that can be used to predict patient response to chemotherapy. However, it is clear that mutations...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: The Anatomical Record: Advances in Integrative Anatomy and Evolutionary Biology
سال: 2007
ISSN: 1932-8486,1932-8494
DOI: 10.1002/ar.20409